Information on this test provided by Athena Diagnostics Quick Guide:
The Early Infantile Epileptic Encephalopaties (EIEE), including Ohtahara Syndrome and early myoclonic epilepsy, are a group of severe epilepsy syndromes characterized by intractable early-onset seizures (generally in the first months of life) and a highly abnormal "burst-suppression" EEG pattern.
EIEE typically presents with treatment-resistant tonic spasms, focal seizures, and rarely, myoclonus. Over time, 40-60% of EIEE patients evolve to West syndrome, characterized by infantile spasms and a highly disorganized "hypsarrhythmia" EEG pattern. In general, many of these patients evolve to Lennox-Gastaut syndrome (often, but not always, between ages 3-6), which presents with mixed seizure types. Testing is indicated for individuals presenting with the above symptoms (tonic seizures, abnormal EEG, and myoclonus).
Reasons to test for EIEE:
Genetic testing can:
- Provide a confirmatory diagnosis
- Genetic testing for STXBP1, ARX, CDKL5 was rated "very useful" and "highly accurate in correct clinical context" by International League Against Epilepsy (ILAE) guidelines
- STXBP1 is mutated in 36% of patients with Ohtahara Syndrome.
- Provide important inheritance and genetic counseling implications
- ARX is an X-linked disorder that is seldom inherited, providing important inheritance implications
- Determine appropriate treatment options
- STXBP1-associated seizures in EIEE may respond better to Vigabatrin
This test is over $10,000. Insurance is willing to pay for some of the cost but we will still owe $2,100 ourselves. We are now on a mission to raise enough money so that Rayleigh can get tested as soon as possible.
Below is the link to a fundraiser I have set up to collect some of the costs needed, please share it with anyone who may be able to help Rayleigh Bug!
If that doesn't work, try this direct link to the Fundrazr: http://fnd.us/c/eKEyc